These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1197264
21. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally]. Janicka L, Majdan M, Dmoszyńska A, Ksiazek A, Berger B, Baranowska E. Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620 [Abstract] [Full Text] [Related]
22. [Pharmacokinetics of ampicillin in patients with kidney allograft]. Iarmolinskii IS, Vasina TA, Goriainov VA. Antibiotiki; 1971 Jul; 16(7):661-3. PubMed ID: 4945581 [No Abstract] [Full Text] [Related]
27. [Importance of residual diuresis in patients with chronic pyelonephritis under constant dialysis treatment]. Erben J. Z Urol Nephrol; 1977 Jan; 70(1):51-8. PubMed ID: 848145 [Abstract] [Full Text] [Related]
28. Supervised intradialytic oral iron administration during erythropoietin therapy. Fourtounas C, Koutsikos D, Dalamangas A, Kapetanaki A, Kostoglou M, Agroyannis B, Tzanatos H, Kopelias I, Bosiolis B. Nephrol Dial Transplant; 1996 Jul; 11(7):1485-6. PubMed ID: 8815424 [No Abstract] [Full Text] [Related]
31. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients]. Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V. Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783 [Abstract] [Full Text] [Related]
32. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?]. Pérez-García R, Rodríguez-Benítez P, Villaverde MT, Valderrábano F. Nefrologia; 2001 Jun; 21(6):606-7. PubMed ID: 11881433 [No Abstract] [Full Text] [Related]
33. [The treatment of acute and chronic renal insufficiency with special reference to extracorporeal dialysis]. PRECHT K, DUTZ H, HAGEMANN I, NATUSCH R, STANGFELD D. Z Arztl Fortbild (Jena); 1962 Mar 15; 56():298-306. PubMed ID: 14488566 [No Abstract] [Full Text] [Related]
34. [Acid-base balance in haemodialyzed patients]. Hrabcáková P, Mydlík M, Molcányiová A. Vnitr Lek; 2002 Oct 15; 48(10):959-61. PubMed ID: 16737145 [Abstract] [Full Text] [Related]
35. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia. Fujita Y, Inoue S, Horiguchi S, Kuki A. Miner Electrolyte Metab; 1995 Oct 15; 21(1-3):50-4. PubMed ID: 7565462 [Abstract] [Full Text] [Related]
36. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis]. Nikolaev AIu, Klepikov PV, Lashutin SV, Kukhtevich AV. Ter Arkh; 1995 Oct 15; 67(5):27-31. PubMed ID: 7638771 [Abstract] [Full Text] [Related]
37. Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting. Pradella M, Cavill I, d'Onofrio G. Clin Lab Haematol; 1996 Dec 15; 18 Suppl 1():35-7. PubMed ID: 9054717 [Abstract] [Full Text] [Related]
38. Obliterative intimal fibrosis in kidneys of dialyzed patients. Tolnai G, Sarkar K, Jaworski ZF, Irvine AH. Can Med Assoc J; 1969 Jan 18; 100(3):116-20. PubMed ID: 5762234 [No Abstract] [Full Text] [Related]
39. Usefulness and risk of erythropoietin therapy in pregnancies of patients with chronic renal insufficiency. Mátyus J, Ujhelyi L, Kárpáti I, Tóth Z, Kakuk G. Nephrol Dial Transplant; 1996 Aug 18; 11(8):1670-1. PubMed ID: 8856240 [No Abstract] [Full Text] [Related]
40. [Care of chronic kidney patients. Possibilities and limits of prevention, treatment and rehabilitation in the clinical stage of chronic kidney insufficiency]. Buchborn E. Internist (Berl); 1983 Sep 18; 24(9):487-93. PubMed ID: 6354966 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]